Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events

Subsequent Events
6 Months Ended
Jun. 30, 2018
Subsequent Events [Abstract]  
Subsequent Events



Subsequent to June 30, 2018, the following events occurred:


  - The Company sold 1,200,780 shares of common stock, at prices ranging from $0.90 to $2.70 per share, for an aggregate amount of $2,200,000.
  - The Company issued warrants to purchase 544,500 shares of common stock at an exercise price of $4.20 per share.
  - Warrant holders exercised warrants to purchase 232,083 shares of common stock at exercise prices of $0.10 and $0.40 per share.
  - A board member was issued 302,000 shares of common stock from the exercise of stock options at exercise prices ranging from $0.08 to $0.63 per share. The aggregate number of shares exercised was 400,000, offset by 98,000 shares used to pay the aggregate exercise price of $98,000 in a cashless transaction.
  - In August 2018, the Company made a payment of $250,000 pursuant to an exclusive worldwide licensing agreement for the production and distribution of precision-dosed, dissolvable cannabis products.